Gene drive debate must include voices from Africa, elsewhere
By Richard Nchabi Kamwi,
STAT
| 06. 15. 2016
As the spread of mosquito-borne diseases has captured headlines in recent months, so too has a novel approach to mosquito control that might one day stop them: gene drive. Although it is in early development, this promising genetic technique could help end the transmission of many deadly pathogens, including malaria.
Gene drives let modifications made to a single organism spread rapidly through the entire population by making sure that targeted genes are passed on to nearly all its offspring. In theory, it would be possible to use gene drives to create mosquitoes that produce sterile offspring, vastly reducing the number that can transmit malaria or other viruses.
...
While vitally important, these conversations have been missing something invaluable: the perspectives of representatives from malaria-affected countries, largely in South and Central America, Africa, and southern Asia.
Continue reading on STAT
Image via Wikimedia
Related Articles
By Mike McIntire, The New York Times | 01.24.2026
Genetic researchers were seeking children for an ambitious, federally funded project to track brain development — a study that they told families could yield invaluable discoveries about DNA’s impact on behavior and disease.
They also promised that the children’s sensitive...
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...